Calcineurin Inhibitor Market Growth Accelerated by Increasing Organ Transplant Procedures


 Calcineurin inhibitors play a crucial role in preventing organ transplant rejection in organ transplant recipients. Calcineurin inhibitors suppress the immune system and prevent the body from rejecting a transplanted organ. Common calcineurin inhibitors include cyclosporine and tacrolimus. The global Calcineurin Inhibitor Market is estimated to be valued at US$ 10.07 Bn in 2024 and is expected to exhibit a CAGR of 10 % over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

Increasing organ transplant procedures is one of the key trends driving the growth of the Calcineurin Inhibitor Market. Calcineurin inhibitors are indispensable drugs for organ transplant recipients and help prevent transplant rejection. The number of organ transplants being performed worldwide has increased substantially in the recent past due to various factors such as rise in the number of donors, technological advancements, and increased awareness about the benefits of organ donation. According to the Global Observatory on Donation and Transplantation, over 140,000 solid organ transplants were carried out globally in 2021, showing an increase of 11% from 2020. This rising volume of organ transplant procedures will augment the demand for calcineurin inhibitors in the coming years.

Segment Analysis
The global calcineurin inhibitor market is dominated by the pharmacotherapy sub-segment, which holds a market share of over 70%. This is because calcineurin inhibitors such as cyclosporine and tacrolimus are predominantly used as immunosuppressive drugs in pharmacotherapy after organ transplant procedures to prevent organ rejection. These drugs inhibit the action of calcineurin, a key component of T-cell activation pathways, thereby facilitating the acceptance of transplanted organs by the recipient’s body.

Key Takeaways
The global calcineurin inhibitor market is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to reach a size of US$ 10.07 Bn by 2024, growing at a CAGR of around 10% during the forecast period.

Regional analysis: North America dominates the global calcineurin inhibitor market and is expected to continue its dominance during the forecast period. This is attributed to the rising organ transplantation procedures and increasing research funding for novel transplant drugs in the region. The market in Asia Pacific is expected to witness the fastest growth over the coming years, spurred by growing health expenditure, increasing focus on transplant procedures by regional governments, and rising incidence of target diseases requiring organ transplants.

Key players operating in the calcineurin inhibitor market are Novartis AG, Amgen, F. Hoffmann-La Roche Ltd, Pfizer Inc., Incyte Corporation, Chiesi Farmaceutici S.p.A., Astellas Pharma Inc., Sanofi SA, Bristol Myers Squibb Company, Mylan N.V., Dr. Reddy's Laboratories Ltd., Senju Pharmaceutical Co. Ltd, Abbott, Lupin Limited, and Vibcare Pharma Pvt. Ltd.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more